-
Signature
-
/s/ Tracy D. Daw as Attorney-in-Fact for Andrew David Oddie
-
Issuer symbol
-
FNKO
-
Transactions as of
-
02 Jan 2025
-
Net transactions value
-
-$306,836
-
Form type
-
4
-
Filing time
-
06 Jan 2025, 17:45:11 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
FNKO |
CLASS A COMMON STOCK |
Options Exercise |
$73,529 |
+7,526 |
+19% |
$9.77 |
47,898 |
02 Jan 2025 |
Direct |
|
| transaction |
FNKO |
CLASS A COMMON STOCK |
Sale |
$378,851 |
-27,712 |
-58% |
$13.67 |
20,186 |
02 Jan 2025 |
Direct |
F1, F2 |
| transaction |
FNKO |
CLASS A COMMON STOCK |
Options Exercise |
$3,498 |
+358 |
+1.8% |
$9.77 |
20,544 |
06 Jan 2025 |
Direct |
|
| transaction |
FNKO |
CLASS A COMMON STOCK |
Sale |
$5,012 |
-358 |
-1.7% |
$14.00 |
20,186 |
06 Jan 2025 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
FNKO |
Option to Purchase Class A Common Stock |
Options Exercise |
$0 |
-7,526 |
-22% |
$0.000000 |
26,874 |
02 Jan 2025 |
CLASS A COMMON STOCK |
7,526 |
$9.77 |
Direct |
F4, F5 |
| transaction |
FNKO |
Option to Purchase Class A Common Stock |
Options Exercise |
$0 |
-358 |
-1.3% |
$0.000000 |
26,516 |
06 Jan 2025 |
CLASS A COMMON STOCK |
358 |
$9.77 |
Direct |
F4, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: